BlackRock Amends Apollo Medical Holdings Stake (SC 13G/A)
Ticker: ASTH · Form: SC 13G/A · Filed: Jan 23, 2024 · CIK: 1083446
| Field | Detail |
|---|---|
| Company | Apollo Medical Holdings, INC. (ASTH) |
| Form Type | SC 13G/A |
| Filed Date | Jan 23, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock updated its passive stake in Apollo Medical Holdings as of year-end 2023.**
AI Summary
BlackRock Inc. filed an amended Schedule 13G/A on January 23, 2024, indicating its ownership of Apollo Medical Holdings Inc. common stock as of December 31, 2023. This amendment, the fourth for BlackRock, updates their passive investment position in the healthcare management company. This matters to investors because BlackRock is a major institutional investor, and changes in their holdings can signal their confidence (or lack thereof) in the company's future prospects, potentially influencing other investors.
Why It Matters
This filing shows BlackRock's updated passive ownership in Apollo Medical Holdings, providing transparency on a significant institutional investor's position. It can influence market perception and investor sentiment towards the stock.
Risk Assessment
Risk Level: low — This is a routine amendment filing by a passive institutional investor and does not indicate any immediate significant risk or opportunity.
Analyst Insight
Investors should note BlackRock's continued passive stake in Apollo Medical Holdings, but this routine update provides no new actionable insights beyond confirming their position as of year-end 2023.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- Apollo Medical Holdings, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 23, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, filed under the Securities Exchange Act of 1934.
Who is the 'subject company' in this filing?
The subject company is Apollo Medical Holdings, Inc., identified by the CIK 0001083446 and business address 1668 S. Garfield Avenue, 2nd Floor, Alhambra, CA 91801.
Who is the 'filed by' entity in this document?
The entity that filed this document is BlackRock Inc., identified by the CIK 0001364742 and business address 50 Hudson Yards, New York, NY 10001.
What is the 'Date of Event Which Requires Filing of this Statement'?
The date of the event which requires the filing of this statement is December 31, 2023.
What rule is BlackRock Inc. filing under for this Schedule 13G/A?
BlackRock Inc. is filing under Rule 13d-1(b), as indicated by the 'X' in the appropriate box on the cover page.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 23, 2024 regarding Apollo Medical Holdings, Inc. (ASTH).